Global Blood Glucose Monitoring BGM Market Overview And Scope:
Global Blood Glucose Monitoring BGM Market Size was estimated at USD 8241.87 million in 2022 and is projected to reach USD 10823.34 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.
The Global Blood Glucose Monitoring BGM Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Blood Glucose Monitoring BGM utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson and Johnson, ARKRAY Inc., Novo Nordisk A/S, Medtronic, Abbott Laboratories, Bayer AG, Ypsomed AG, Sanofi
Global Blood Glucose Monitoring BGM Market Segmentation
By Type, Blood Glucose Monitoring BGM market has been segmented into:Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
By Application, Blood Glucose Monitoring BGM market has been segmented into:
Hospital Use
Clinic Use
Household
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Blood Glucose Monitoring BGM market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Blood Glucose Monitoring BGM market.
Top Key Players Covered in Blood Glucose Monitoring BGM market are:
Becton
Dickinson and Co.
Terumo Corporation
Acon Laboratories Inc.
Roche Diagnostics Ltd.
Johnson and Johnson
ARKRAY Inc.
Novo Nordisk A/S
Medtronic
Abbott Laboratories
Bayer AG
Ypsomed AG
Sanofi
Objective to buy this Report:
1. Blood Glucose Monitoring BGM analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Blood Glucose Monitoring BGM market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Blood Glucose Monitoring BGM Market by Type
5.1 Blood Glucose Monitoring BGM Market Overview Snapshot and Growth Engine
5.2 Blood Glucose Monitoring BGM Market Overview
5.3 Blood Glucose Meters
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Blood Glucose Meters: Geographic Segmentation
5.4 Continuous Glucose Monitoring Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Continuous Glucose Monitoring Devices: Geographic Segmentation
5.5 Lancets
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Lancets: Geographic Segmentation
5.6 Blood Glucose Testing Strips
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Blood Glucose Testing Strips: Geographic Segmentation
Chapter 6: Blood Glucose Monitoring BGM Market by Application
6.1 Blood Glucose Monitoring BGM Market Overview Snapshot and Growth Engine
6.2 Blood Glucose Monitoring BGM Market Overview
6.3 Hospital Use
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Use: Geographic Segmentation
6.4 Clinic Use
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic Use: Geographic Segmentation
6.5 Household
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Household: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Blood Glucose Monitoring BGM Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Blood Glucose Monitoring BGM Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Blood Glucose Monitoring BGM Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BECTON
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 DICKINSON AND CO.
7.4 TERUMO CORPORATION
7.5 ACON LABORATORIES INC.
7.6 ROCHE DIAGNOSTICS LTD.
7.7 JOHNSON AND JOHNSON
7.8 ARKRAY INC.
7.9 NOVO NORDISK A/S
7.10 MEDTRONIC
7.11 ABBOTT LABORATORIES
7.12 BAYER AG
7.13 YPSOMED AG
7.14 SANOFI
Chapter 8: Global Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Blood Glucose Meters
8.2.2 Continuous Glucose Monitoring Devices
8.2.3 Lancets
8.2.4 Blood Glucose Testing Strips
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital Use
8.3.2 Clinic Use
8.3.3 Household
8.3.4 Other
Chapter 9: North America Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Blood Glucose Meters
9.4.2 Continuous Glucose Monitoring Devices
9.4.3 Lancets
9.4.4 Blood Glucose Testing Strips
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital Use
9.5.2 Clinic Use
9.5.3 Household
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Blood Glucose Meters
10.4.2 Continuous Glucose Monitoring Devices
10.4.3 Lancets
10.4.4 Blood Glucose Testing Strips
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital Use
10.5.2 Clinic Use
10.5.3 Household
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Blood Glucose Meters
11.4.2 Continuous Glucose Monitoring Devices
11.4.3 Lancets
11.4.4 Blood Glucose Testing Strips
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital Use
11.5.2 Clinic Use
11.5.3 Household
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Blood Glucose Meters
12.4.2 Continuous Glucose Monitoring Devices
12.4.3 Lancets
12.4.4 Blood Glucose Testing Strips
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital Use
12.5.2 Clinic Use
12.5.3 Household
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Blood Glucose Meters
13.4.2 Continuous Glucose Monitoring Devices
13.4.3 Lancets
13.4.4 Blood Glucose Testing Strips
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital Use
13.5.2 Clinic Use
13.5.3 Household
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Blood Glucose Monitoring BGM Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Blood Glucose Meters
14.4.2 Continuous Glucose Monitoring Devices
14.4.3 Lancets
14.4.4 Blood Glucose Testing Strips
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital Use
14.5.2 Clinic Use
14.5.3 Household
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Blood Glucose Monitoring BGM Scope:
|
Report Data
|
Blood Glucose Monitoring BGM Market
|
|
Blood Glucose Monitoring BGM Market Size in 2025
|
USD XX million
|
|
Blood Glucose Monitoring BGM CAGR 2025 - 2032
|
XX%
|
|
Blood Glucose Monitoring BGM Base Year
|
2024
|
|
Blood Glucose Monitoring BGM Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson and Johnson, ARKRAY Inc., Novo Nordisk A/S, Medtronic, Abbott Laboratories, Bayer AG, Ypsomed AG, Sanofi.
|
|
Key Segments
|
By Type
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
By Applications
Hospital Use
Clinic Use
Household
Other
|
